These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14986780)

  • 1. The biochemical bases of the placebo effect.
    de la Fuente-Fernández R; Stoessl AJ
    Sci Eng Ethics; 2004 Jan; 10(1):143-50. PubMed ID: 14986780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Stoessl AJ
    Trends Neurosci; 2002 Jun; 25(6):302-6. PubMed ID: 12086748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemical bases for reward. Implications for the placebo effect.
    De La Fuente-Fernández R; Stoessl AJ
    Eval Health Prof; 2002 Dec; 25(4):387-98. PubMed ID: 12449082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo effect and dopamine release.
    de la Fuente-Fernández R; Lidstone S; Stoessl AJ
    J Neural Transm Suppl; 2006; (70):415-8. PubMed ID: 17017561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The placebo-reward hypothesis: dopamine and the placebo effect.
    de la Fuente-Fernández R
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S72-4. PubMed ID: 20083013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo mechanisms and reward circuitry: clues from Parkinson's disease.
    de la Fuente-Fernández R; Schulzer M; Stoessl AJ
    Biol Psychiatry; 2004 Jul; 56(2):67-71. PubMed ID: 15231437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
    Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
    Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine release in human ventral striatum and expectation of reward.
    de la Fuente-Fernández R; Phillips AG; Zamburlini M; Sossi V; Calne DB; Ruth TJ; Stoessl AJ
    Behav Brain Res; 2002 Nov; 136(2):359-63. PubMed ID: 12429397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Great expectations: the placebo effect in Parkinson's disease.
    Lidstone SC
    Handb Exp Pharmacol; 2014; 225():139-47. PubMed ID: 25304530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Placebo effect in Parkinson's disease].
    Miwa H
    Brain Nerve; 2007 Feb; 59(2):139-46. PubMed ID: 17380778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.
    Quattrone A; Barbagallo G; Cerasa A; Stoessl AJ
    Mov Disord; 2018 Aug; 33(8):1213-1227. PubMed ID: 30230624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Ruth TJ; Sossi V; Schulzer M; Calne DB; Stoessl AJ
    Science; 2001 Aug; 293(5532):1164-6. PubMed ID: 11498597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the placebo effect: contributions from neuroimaging.
    Lidstone SC; Stoessl AJ
    Mol Imaging Biol; 2007; 9(4):176-85. PubMed ID: 17334853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
    Remy P; Doder M; Lees A; Turjanski N; Brooks D
    Brain; 2005 Jun; 128(Pt 6):1314-22. PubMed ID: 15716302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo responses in Parkinson's disease.
    Lou JS
    Int Rev Neurobiol; 2020; 153():187-211. PubMed ID: 32563288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 19. The placebo effect in neurological disorders.
    de la Fuente-Fernández R; Schulzer M; Stoessl AJ
    Lancet Neurol; 2002 Jun; 1(2):85-91. PubMed ID: 12849512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.